Search Results 1161-1170 of 18780 for autoimmune hepatitis

  1. End-stage renal disease - Doctors and departments - Mayo Clinic

    Kidney disease and chronic liver disease; Genetics behind kidney diseases; Understanding what underlies autosomal dominant polycystic kidney disease and ...

  2. End-stage renal disease - Doctors and departments - Mayo Clinic

    Kidney disease and chronic liver disease; Genetics behind kidney diseases; Understanding what underlies autosomal dominant polycystic kidney disease and ...

  3. End-stage renal disease - Doctors and departments - Mayo Clinic

    Kidney disease and chronic liver disease; Genetics behind kidney diseases; Understanding what underlies autosomal dominant polycystic kidney disease and ...

  4. Chronic hives - Diagnosis and treatment - Mayo Clinic

    Learn how this long-lasting skin condition that causes painful, itchy, recurring welts is diagnosed and what treatments may offer relief.

  5. Male breast cancer - Symptoms and causes - Mayo Clinic

    Liver disease. Certain conditions, such as cirrhosis of the liver, can change the balance of hormones in the body. This raises the risk of male breast ...

  6. Biotherapeutics - 2021 Archives - Mayo Clinic News Network

    Science Saturday: Regenerative technology uncovers new discoveries in liver disease. Susan Buckles. November 20, 2021. Mayo Clinic Symposium on Regenerative ...

  7. A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Anti-N-Methyl-D-Aspartic Acid Receptor (NMDAR) Or Anti-Leucine-Rich Glioma-Inactivated 1 (LGI1) Encephalitis (Cielo) - Mayo Clinic

    * Onset of autoimmune encephalitis (AIE) symptoms \<=9 months before randomization * ... * Positive hepatitis B (HBV) and hepatitis C (HCV) test at screening * ...

  8. Overview - RNA Nanotherapeutics: Tushar C. Patel

    Patel is working to identify new target molecules and mechanisms for liver disease and cancers through the study and use of extracellular vesicles, noncoding ...

  9. Methenamine (oral route) - Mayo Clinic

    Liver disease (severe)—Patients with severe liver disease who take methenamine may have an increase in symptoms of their liver disease. Back to top. Proper ...

  10. Abrocitinib (oral route) - Mayo Clinic

    Liver disease, severe—Use is not recommended in patients with these conditions. Kidney disease, mild or moderate—Use with caution. The effects may be increased ...